Monograph Title | Section Sort descending | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
CHORIONIC GONADOTROPIN FOR INJECTION | ADDITIONAL REQUIREMENTS | USP41–NF36 | 1982 | 29-Jun-2018 | 1-Jul-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 2 of USP Reference Standards <11>: Delete USP Endotoxin RS |
WATER FOR INJECTION | ADDITIONAL REQUIREMENTS | USP41–NF36 | 4345 | 26-Oct-2018 | 1-Nov-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Delete • USP Reference Standards <11> USP 1,4-Benzoquinone RS |
MICONAZOLE NITRATE | ADDITIONAL REQUIREMENTS | First Supplement to USP41–NF36 | Online | 27-Jul-2018 | 1-Aug-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | (Note: This errata applies to the new USP-NF ONLINE platform only.) Line 4 of USP Reference Standards <11>: Change USP Doxazosin Related Compound C RS to: USP Miconazole Related Compound C RS AND Line 7 of USP Reference… Read More |
CEFDINIR | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Cefdinir Related Compound A RS: Change 413.43 to: 413.42 |
WATER FOR HEMODIALYSIS | ADDITIONAL REQUIREMENTS | USP41–NF36 | 4345 | 26-Oct-2018 | 1-Nov-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Delete • USP Reference Standards <11> USP 1,4-Benzoquinone RS |
SALIX SPECIES BARK | ADDITIONAL REQUIREMENTS | USP42–NF37 | 5185 | 25-Jan-2019 | 1-Feb-2019 | NA | NA | In Labeling: Change The label states the Latin binomial(s) of one or several Salix species included in the article. to: The label states the Latin binomial(s) of one or several Salix species included in the article. Dosage forms… Read More |
ISOPROPYL ISOSTEARATE | ADDITIONAL REQUIREMENTS | First Supplement to USP41–NF36 | Online | 28-Sep-2018 | 1-Oct-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | This erratum applies to the new USP-NF ONLINE platform only. Line 2 of USP Reference Standards <11>: Change USP Isostearyl Isostearate RS to: USP Isopropyl Isostearate RS |
CEFDINIR CAPSULES | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Cefdinir Related Compound A RS: Change 413.43 to: 413.42 AND In USP Reference Standards 〈11〉/USP Cefdinir Related Compound B RS: Change C14H13N4O4S… Read More |
STERILE WATER FOR INHALATION | ADDITIONAL REQUIREMENTS | USP41–NF36 | 4346 | 26-Oct-2018 | 1-Nov-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Delete • USP Reference Standards <11> USP 1,4-Benzoquinone RS |
FILGRASTIM | ADDITIONAL REQUIREMENTS | USP43–NF38 | Online | 29-May-2020 | 1-Jun-2020 | NA | NA | Change USP Reference Standards <11> to: USP Reference Standards <11> USP Filgrastim RS |
CEFDINIR FOR ORAL SUSPENSION | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Cefdinir Related Compound A RS: Change 413.43 to: 413.42 AND In USP Reference Standards 〈11〉/USP Cefdinir Related Compound B RS: Change C14H13N4O4S… Read More |
STERILE WATER FOR INJECTION | ADDITIONAL REQUIREMENTS | USP41–NF36 | 4346 | 26-Oct-2018 | 1-Nov-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Delete • USP Reference Standards <11> USP 1,4-Benzoquinone RS |
PRAVASTATIN SODIUM | ADDITIONAL REQUIREMENTS | First Supplement to USP41–NF36 | Online | 28-Sep-2018 | 1-Oct-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | This erratum applies to the new USP-NF ONLINE platform only. Line 2 of USP Reference Standards <11>: Change USP Pravastatin Related Compound A RS to: USP Pravastatin 1,1,3,3-Tetramethylbutylamine RS |
SALIX SPECIES BARK DRY EXTRACT | ADDITIONAL REQUIREMENTS | USP42–NF37 | 5187 | 25-Jan-2019 | 1-Feb-2019 | NA | NA | In Labeling: Change It meets the labeling requirements of Botanical Extracts <565>. to: It meets the labeling requirements of Botanical Extracts <565>. Dosage forms prepared with this article should bear the following… Read More |
TETRACYCLINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/Labeling | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change Where tetracycline hydrochloride must be sterile or subjected to further processing during the preparation of injectable dosage forms to ensure acceptable levels of bacterial endotoxins, it is so labeled. to: Where Tetracycline Hydrochloride must be… Read More |
OIL-SOLUBLE VITAMINS WITH MINERALS TABLETS | ADDITIONAL REQUIREMENTS/Labeling | USP43–NF38 | 5378 | 30-Oct-2020 | 1-Nov-2020 | NA | NA | In footnote 1: Change 1 mg of -alpha tocopheryl acetate to: 1 mg of all-rac-alpha tocopheryl acetate |
OIL-SOLUBLE VITAMINS TABLETS | ADDITIONAL REQUIREMENTS/Labeling | USP43–NF38 | 5356 | 24-Apr-2020 | 1-May-2020 | NA | NA | In footnote 1: Change -alpha-tocopheryl to: all-rac-alpha-tocopheryl AND Change USP Vitamin E unit to: USP Vitamin E Unit AND Change 2R-alphatocopherol to: 2R-alpha-tocopherol |
DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP41–NF36 | 1447 | 26-Oct-2018 | 1-Nov-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Line 2 of USP Ethinyl Estradiol Related Compound B RS: Change 19-Nor-17ɑ-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol. C20H22O2 294.39 to: 19-Nor-17ɑ-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol… Read More |
RIZATRIPTAN BENZOATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP41–NF36 | 3662 | 26-Oct-2018 | 1-Nov-2018 | USP43–NF38 | Second Supplement to USP41–NF36 | Line 6 of USP Rizatriptan Benzoate System Suitability Mixture RS: Change 269.34) to: 269.35) |
MESO-ZEAXANTHIN PREPARATION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In USP meso-Zeaxanthin RS: Change (3R,3′S-meso)-Zeaxanthin. to: (3R,3′S)-Zeaxanthin. |
PAROXETINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | First Supplement to USP42–NF37 | 8788 | 27-Sep-2019 | 1-Oct-2019 | NA | NA | In USP Paroxetine Related Compound G RS: Change 405.46 to: 441.92 |
AMLODIPINE AND ATORVASTATIN TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 265 | 20-Nov-2020 | 1-Dec-2020 | NA | NA | In USP Atorvastatin Related Compound H RS: Change 540.62 to: 540.64 |
LANSOPRAZOLE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 2551 | 25-Jun-2021 | 1-Jul-2021 | NA | NA | In USP Lansoprazole Related Compound B RS: Change 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl] methyl]sulfanyl]-1H-benzimidazole. C16H14F3N3OS 353.36 to: 2-{[(3-Methyl-4-(2,2,2-… Read More |
SUCCINYLCHOLINE CHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In USP Succinylmonocholine Chloride RS: Change Ethanaminium, 2-(carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride. to: Ethanaminium, 2-(3-carboxy-1-oxopropoxy)-N,N,N-trimethyl-, chloride; Also… Read More |
CETIRIZINE HYDROCHLORIDE ORALLY DISINTEGRATING TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 897 | 31-May-2019 | 1-Jun-2019 | NA | NA | In USP Cetirizine Related Compound A RS: Change 2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetic acid, ethyl ester dihydrochloride. C23H29ClN2O3 · 2HCl 489.86 to: (RS)-2-[2… Read More |
FEXOFENADINE HYDROCHLORIDE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 1830 | 30-Aug-2019 | 1-Sep-2019 | NA | NA | In USP Fexofenadine Related Compound A RS: Change Benzeneacetic acid, 4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl. C32H37NO4 538.12 to: 2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl}phenyl… Read More |
MIRTAZAPINE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | Online | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Mirtazapine Resolution Mixture RS: Change Impurity D: 1,2,3,4,10,14b-Hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine. to: Impurity D: [Note–This impurity may be available either as the free base form or as the hydrochloride salt… Read More |
PANTOPRAZOLE SODIUM | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 25-Mar-2022 | 1-Apr-2022 | NA | NA | In USP Pantoprazole Related Compound E RS: Change A mixture of the stereoisomers of 6,6′-bis(difluoromethoxy)-2,2′-bis[[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl]-1H,1′H-5,5′-bibenzimidazolyl. to: 6,6′-Bis(difluoromethoxy)-2,2′-bis[[(3,4-… Read More |
TIAGABINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 29-Oct-2021 | 1-Nov-2021 | NA | NA | In USP Tiagabine Hydrochloride RS: Delete [NOTE—Available in monohydrate form.] |
ATORVASTATIN CALCIUM TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 418 | 20-Nov-2020 | 1-Dec-2020 | NA | NA | In USP Atorvastatin Related Compound H RS: Change 540.62 to: 540.64 |
CLOMIPHENE CITRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 1068 | 31-May-2019 | 1-Jun-2019 | NA | NA | In USP Clomiphene Related Compound A RS: Change (E,Z)-2-[4-(1,2-Diphenylethyl)phenoxy]-N,N-diethylethanamine hydrochloride. to: (E,Z)-2-[4-(1,2-Diphenylvinyl)phenoxy]-N,N-diethylethanamine… Read More |
FEXOFENADINE HYDROCHLORIDE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Revision Bulletin (Official November 01, 2018) | Online | 30-Aug-2019 | 1-Sep-2019 | NA | NA | In USP Fexofenadine Related Compound A RS: Change Benzeneacetic acid, 4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl. to: 2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl}phenyl)-2-methylpropanoic acid; Also known as Benzeneacetic… Read More |
MIRTAZAPINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | Online | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Mirtazapine Resolution Mixture RS: Change Impurity D: 1,2,3,4,10,14b-Hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine. to: Impurity D: [Note–This impurity may be available either as the free base form or as the hydrochloride salt… Read More |
LEVALBUTEROL HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 2518 | 26-Apr-2019 | 1-May-2019 | NA | NA | In USP Levalbuterol Related Compound D RS: Change 5-{2-[(1,1-Dimethylethyl)amino]-1-hydroxyethyl}-2-hydroxy-benzaldehyde. C13H19NO3 237.29 ▲[NOTE—This may be available as the sulfate salt (2:1).]▲ (USP… Read More |
GEMCITABINE FOR INJECTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 2094 | 30-Jul-2021 | 1-Aug-2021 | NA | NA | In USP Cytosine RS: Change 2(1H)-Pyrimidinone, 4-amino-. to: Cytosine. |
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP42–NF37 | 487 | 27-Sep-2019 | 1-Oct-2019 | NA | NA | In USP Bendamustine Related Compound B RS: Change 4-(1-Methyl-5-morpholino-1H-benzimidazol-2-yl)butanoic acid. C16H21N3O3 303.36 to: 4-(1-Methyl-5-morpholino-1H-benzimidazol-2-yl)… Read More |
SERTRALINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 26-Mar-2021 | 1-May-2021 | NA | NA | In USP Sertraline Hydrochloride Racemic Mixture RS: Change C17H17Cl2 · HCl to: C17H17Cl2N · HCl |
MICONAZOLE NITRATE TOPICAL POWDER | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | First Supplement to USP41–NF36 | 8355 | 25-May-2018 | 1-Jun-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 2 of USP Miconazole Related Compound C RS: Change 2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethan-1-amine. C15H13Cl4NO 365.08 to: 2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethan-1-amine… Read More |
AMIODARONE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | Online | 20-Nov-2020 | 1-Dec-2020 | NA | NA | In USP Amiodarone Related Compound H RS: Change 2-Chloro-N,N-diethylethanamine. C6H14ClN 135.64 to: 2-Chloro-N,N-diethylethanamine hydrochloride. C6H14ClN · HCl 172.09 |
CAPTOPRIL | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | In USP Captopril Disulfide RS: Change L-Proline, 1,1ʹ-[dithiobis(2-methyl-1-oxo-3,1-propanediyl)]bis-[S-(R*,R*)]-. to: (2ʹS)-[(2S,2ʹS)-3,3ʹ-Disulfanediylbis(2-methylpropanoyl)]di-L-proline. |
DOXYCYCLINE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Revision Bulletin (Official August 01, 2018) | Online | 30-Aug-2019 | 1-Sep-2019 | NA | NA | In USP Fexofenadine Related Compound A RS: Change Benzeneacetic acid, 4-[1-oxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl. to: 2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl}phenyl)-2-methylpropanoic acid; Also known as Benzeneacetic… Read More |
AMLODIPINE AND OLMESARTAN MEDOXOMIL TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | Online | 26-Feb-2021 | 1-Mar-2021 | NA | NA | In USP Amlodipine Related Compound A RS: Change 522.93 to: 522.94 |
ZIPRASIDONE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 4699 | 30-Jul-2021 | 1-Aug-2021 | NA | NA | In USP Ziprasidone Related Compound F RS: Change 2-(2-Amino-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-4-chlorophenyl)acetic acid. C21H23ClN4O2S 430.95 to: Sodium 2-(2-… Read More |
ONDANSETRON ORALLY DISINTEGRATING TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Jan-2022 | 1-Feb-2022 | NA | NA | In USP Ondansetron Related Compound A RS: Change 3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one hydrochloride. C16H20N2O · HCl 292.80 to: 3-[(Dimethylamino)methyl]-9-methyl-1,2,… Read More |
DOXEPIN HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP41–NF36 | 1404 | 25-May-2018 | 1-Jun-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 2 of USP Doxepin Related Compound C RS: Change (E,Z)-3-(Dibenzo[b,e]oxepin-11(6H-ylidene)-N-methyl-propoan-1-amine. to: (E,Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-… Read More |
AMITRIPTYLINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | In USP Amitriptyline Related Compound B RS: Change 295.42 to: 295.43 |
DOXAZOSIN MESYLATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 29-Oct-2021 | 1-Nov-2021 | NA | NA | In USP Doxazosin Related Compound D RS: Change 1,4-Benzodioxane-2-carboxylic acid. C9H8O5 196.16 to: 1,4-Benzodioxane-2-carboxylic acid. C9H8O4 180.16 |
CETIRIZINE HYDROCHLORIDE ORALLY DISINTEGRATING TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 915 | 24-Apr-2020 | 1-May-2020 | NA | NA | In USP Cetirizine Related Compound A RS: Change 506.98 to: 506.97 |
GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USP43–NF38 | 2128 | 26-Mar-2021 | 1-Apr-2021 | NA | NA | In USP Glyburide Related Compound A RS: Change 368.84 to: 368.83 |